The CDC and FDA paused the J&J COVID-19 vaccine on April 13, 2021. NBC LX asks Mobile Health CEO Andrew Shulman how this will affect our nation’s vaccination efforts.
A STEEP CLIMB BACK
“The pausing of the J&J COVID-19 vaccine following isolated blood clots will have a lasting effect on vaccine hesitancy,” said Shulman. “Even prior to the pause, Mobile Health saw 20 percent of scheduled appointments refuse the J&J vaccine, due to misinformation,” he said. The J&J single-shot vaccine has been intended for rural areas, where vaccine hesitancy is higher. “We are going to have a steep climb back (from vaccine hesitancy), but President Biden assures us we’ll have plenty of Pfizer and Moderna vaccine.”
The Johnson & Johnson pause resulted in a drop in vaccinations across the United States. In just one week, the rate of new vaccinations dropped by 1.3 million.
THE UNVACCINATED WORKFORCE
With a rise in vaccine hesitancy, many employers risk high levels of transmission in their workplace. What can you do to protect your people? Weekly testing is key in preventing and containing an outbreak.